Education
About Us
Working with TipRanks
Follow Us
Climb Bio (CLYM)
NASDAQ:CLYM
Budoprutug
Primary Membranous Nephropathy
Phase II
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Jul 24, 2025
―
Budoprutug
Healthy Volunteers
Early Phase I
Recruiting
A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers
Jul 21, 2025
―
Budoprutug
Immune Thrombocytopenia (Itp), Itp, Biologics, Monoclonal, Anti-Cd19
Phase I/II
Recruiting
A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
Jun 20, 2025
―
Budoprutug
Systemic Lupus Erythematosus
Phase I
Recruiting
A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
May 06, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Climb Bio (CLYM) have in its pipeline
CLYM is currently developing the following drugs: Budoprutug, Budoprutug, Budoprutug. These drug candidates are in various stages of clinical development as the company works toward FDA approval.